血脑屏障
药物开发
疾病
药品
医学
脑病
神经科学
药理学
生物
中枢神经系统
内科学
标识
DOI:10.1080/13543784.2019.1627325
摘要
In 2019, there is not a single biologic that is FDA approved for brain disorders wherein the drug crosses the blood-brain barrier (BBB). Bevacizumab is approved for brain cancer, but bevacizumab do...
科研通智能强力驱动
Strongly Powered by AbleSci AI